BIT:1CVS - Euronext Milan - US1266501006 - Common Stock - Currency: EUR
BIT:1CVS (2/24/2025, 7:00:00 PM)
60.51
-2.18 (-3.48%)
The current stock price of 1CVS.MI is 60.51 EUR.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CVS.DE | CVS HEALTH CORP | 11.67 | 75.81B | ||
FME.DE | FRESENIUS MEDICAL CARE AG | 16.1 | 26.45B | ||
FRE.DE | FRESENIUS SE & CO KGAA | 36.05 | 21.93B | ||
V3V.DE | FAMICORD AG | 29.86 | 73.74M |
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. The company is headquartered in Woonsocket, Rhode Island and currently employs 300,000 full-time employees. The firm operates in four segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Its Health Care Benefits segment offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services segment provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services, including pharmacy patient care programs, diagnostic testing and vaccination administration.
CVS HEALTH CORP
1 Cvs Dr
Woonsocket RHODE ISLAND US
Employees: 259500
Company Website: https://cvshealth.com/
Investor Relations: https://investors.cvshealth.com
Phone: 14017651500
The current stock price of 1CVS.MI is 60.51 EUR. The price decreased by -3.48% in the last trading session.
The exchange symbol of CVS HEALTH CORP is 1CVS and it is listed on the Euronext Milan exchange.
1CVS.MI stock is listed on the Euronext Milan exchange.
33 analysts have analysed 1CVS.MI and the average price target is 59.54 EUR. This implies a price decrease of -1.61% is expected in the next year compared to the current price of 60.51. Check the CVS HEALTH CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CVS HEALTH CORP (1CVS.MI) has a market capitalization of 76.15B EUR. This makes 1CVS.MI a Large Cap stock.
CVS HEALTH CORP (1CVS.MI) currently has 259500 employees.
The Revenue of CVS HEALTH CORP (1CVS.MI) is expected to grow by 4.44% in the next year. Check the estimates tab for more information on the 1CVS.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CVS HEALTH CORP (1CVS.MI) has a dividend yield of 4.09%. The yearly dividend amount is currently 2.65. Check the full fundamental report for a detailed analysis of 1CVS.MI dividend history, reliability and sustainability.
CVS HEALTH CORP (1CVS.MI) will report earnings on 2025-04-29, before the market open.
The PE ratio for CVS HEALTH CORP (1CVS.MI) is 11.73. This is based on the reported non-GAAP earnings per share of 5.16 and the current share price of 60.51 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1CVS.MI.
ChartMill assigns a technical rating of 3 / 10 to 1CVS.MI.
ChartMill assigns a fundamental rating of 4 / 10 to 1CVS.MI. There are concerns on the financial health of 1CVS.MI while its profitability can be described as average.
Over the last trailing twelve months 1CVS.MI reported a non-GAAP Earnings per Share(EPS) of 5.16. The EPS decreased by -37.99% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.24% | ||
ROA | 1.82% | ||
ROE | 6.11% | ||
Debt/Equity | 0.83 |
ChartMill assigns a Buy % Consensus number of 76% to 1CVS.MI. The Buy consensus is the average rating of analysts ratings from 33 analysts.
For the next year, analysts expect an EPS growth of 10.12% and a revenue growth 4.44% for 1CVS.MI